Andrew Satlin

Follow

Generating author description...

All published works

Action	Title	Year	Authors
+	Design of a Bayesian adaptive phase 2 proof‐of‐concept trial for BAN2401, a putative disease‐modifying monoclonal antibody for the treatment of Alzheimer's disease	2016	Andrew Satlin Jinping Wang Veronika Logovinsky Scott Berry Chad J. Swanson Shobha Dhadda Donald A. Berry
+	O1‐06‐05: First‐in‐human study of E2609, a novel BACE1 inhibitor, demonstrates prolonged reductions in plasma beta‐amyloid levels after single dosing	2012	Robert Lai Bruce Albala June Kaplow Jagadeesh Aluri Mark Yen Andrew Satlin
+	Comments on “Effects of Interrater Reliability of Psychopathologic Assessment on Power and Sample Size Calculations in Clinical Trials’ by Muller and Associates	2003	Andrew Satlin G. Rosenkranz H. Pöhlmann

Common Coauthors

Coauthor	Papers Together
Scott Berry	1
Shobha Dhadda	1
G. Rosenkranz	1
Bruce Albala	1
Veronika Logovinsky	1
Mark Yen	1
Donald A. Berry	1
Chad J. Swanson	1
H. Pöhlmann	1
June Kaplow	1
Robert Lai	1
Jagadeesh Aluri	1
Jinping Wang	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+ PDF Chat	Phase II Trial Design with Bayesian Adaptive Randomization and Predictive Probability	2012	Guosheng Yin Nan Chen J. Jack Lee	1
+	Bayesian Adaptive Methods for Clinical Trials	2010	Cody Hamilton	1
+	A Bayesian Dose-Finding Design Adapting to Efficacy and Tolerability Response	2012	S. Krishna Padmanabhan Scott Berry Vladimir Dragalin Michael Krams	1
+	Viewpoints on the FDA Draft Adaptive Designs Guidance from the PhRMA Working Group	2010	Paul Gallo Keaven M. Anderson Christy Chuang‐Stein Vladimir Dragalin Brenda Gaydos Michael Krams José Cirı́aco Pinheiro	1
+	Improving Alzheimer's disease phase II clinical trials	2012	Barry Greenberg María C. Carrillo J. Michael Ryan Michael Gold Kim P. Gallagher Michael Grundman Robert Berman T. Ashwood Eric Siemers	1
+	Adaptive Designs in Clinical Drug Development—An Executive Summary of the PhRMA Working Group	2006	Paul Gallo Christy Chuang‐Stein Vladimir Dragalin Brenda Gaydos Michael Krams José Cirı́aco Pinheiro	1
+	Adaptive clinical trials in oncology	2011	Donald A. Berry	1
+	A Bayesian dose-finding trial with adaptive dose expansion to flexibly assess efficacy and safety of an investigational drug	2010	Scott Berry Walter Spinelli Gary S. Littman John Z. Liang Parvin Fardipour Donald A. Berry Roger Lewis Michael Krams	1
+	Adaptive, group sequential and decision theoretic approaches to sample size determination	2006	Cyrus R. Mehta Nitin R. Patel	1
+	Interim Analysis in Clinical Trials: The Role of the Likelihood Principle	1987	Donald A. Berry	1
+	Bayesian clinical trials	2006	Donald A. Berry	1
+	Sample size and the probability of a successful trial	2006	Christy Chuang‐Stein	1
+ PDF Chat	The need for thorough phase II studies in medicines development for Alzheimer’s disease	2015	Julian Gray David Fleet Bengt Winblad	1
+	Bayesian Adaptive Methods for Clinical Trials	2010	Scott Berry Bradley P. Carlin J. Jack Lee Peter Müller	1